NCT01932099View on ClinicalTrials.gov

TranScatheter Aortic Valve RepLacement System US Feasibility Trial

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2018

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Transcatheter aortic valve replacement

Direct Flow Medical Transcatheter Aortic Valve System is indicated for use in aortic stenosis for patients at extreme surgical risk for aortic valve replacement.

Trial Locations (6)

10032

Columbia Univ. Medical Center, New York

44195

Cleveland CLinic, Cleveland

48202

Henry Ford Hospital, Detroit

60611

Northwestern Memorial Hospital, Chicago

63110

Washington University Hospital, St Louis

95817

UC Davis Medical Center, Sacramento

Sponsors
All Listed Sponsors
lead

Direct Flow Medical, Inc.

INDUSTRY